ACCORDI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.010
EU - Europa 373
AS - Asia 197
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 3.585
Nazione #
US - Stati Uniti d'America 2.987
CN - Cina 172
DE - Germania 122
IT - Italia 64
FI - Finlandia 53
GB - Regno Unito 35
SE - Svezia 35
RU - Federazione Russa 24
CA - Canada 23
UA - Ucraina 20
IN - India 13
VN - Vietnam 12
IE - Irlanda 8
NL - Olanda 7
AU - Australia 2
FR - Francia 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 3.585
Città #
Fairfield 537
Woodbridge 352
Chandler 326
Ann Arbor 251
Cambridge 233
Ashburn 213
Houston 185
Seattle 179
Wilmington 162
Jacksonville 58
San Diego 57
Princeton 45
Beijing 42
Medford 36
Helsinki 34
Des Moines 28
Padova 28
Boardman 21
Nanjing 21
Shenyang 14
Dong Ket 12
North York 12
New York 11
Jinan 10
Guangzhou 9
Dublin 8
Jiaxing 8
Ottawa 8
Chicago 7
Dearborn 7
Zhengzhou 7
Falls Church 6
Hebei 6
London 6
Los Angeles 6
Norwalk 5
Hefei 4
Kunming 4
Ogden 4
Shanghai 4
Amsterdam 3
Changsha 3
Fuzhou 3
Gunzenhausen 3
Hangzhou 3
Indiana 3
Kharkiv 3
Milan 3
Nanchang 3
Rovigo 3
Tianjin 3
Wandsworth 3
Borås 2
Eboli 2
Hounslow 2
Lanzhou 2
Minneapolis 2
Portland 2
Pune 2
Rockville 2
Salerno 2
San Francisco 2
Selvazzano Dentro 2
Taiyuan 2
Taizhou 2
Tappahannock 2
Baotou 1
Bristol 1
Buccinasco 1
Chiswick 1
Citta Sant'angelo 1
Cividale del Friuli 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dalmine 1
Delhi 1
Grafing 1
Hamilton 1
Jinhua 1
Johannesburg 1
Kilburn 1
Miami 1
Montréal 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Nürnberg 1
Orange 1
Qingdao 1
Quzhou 1
Ravenna 1
Rosà 1
Roxbury 1
Sant'elena 1
Sassari 1
Shenzhen 1
Sofia 1
Strathfield 1
Sydney 1
São Paulo 1
Totale 3.064
Nome #
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 160
Hovering between death and life: Natural apoptosis and phagocytes in the blastogenetic cycle of the colonial ascidian Botryllus schlosseri 140
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 136
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL 135
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 133
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 132
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 132
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 120
Expression and role of hERG1 channels in pediatric acute lymphoblastic Leukemias: Shortcoming of drug resistance by hERG1 channel inhibitors in stoma-supported leukaemia cell cultures in vitro. 118
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 117
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 116
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 112
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia 110
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All) 110
Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells 110
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 107
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 106
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 105
Annexin 2A sustains glioblastoma cell dissemination and proliferation 99
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction 98
Reverse Phase Protein Array (RPPA) of High Risk ALL 94
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 89
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. 87
AMPK INHIBITION INDUCES APOPTOSIS IN PEDIATRIC B-ALL CELLS WITH MLL GENE REARRANGEMENTS 84
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. 84
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 84
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. 81
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. 79
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction 74
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 69
Validation by RQ-PCR and flow cytometry of alpha-defensin 1-3 (DEFA 1-3) overexpression in relapsed and refractory acute lymphoblastic leucemia. 68
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma 67
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 61
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy 57
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 45
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 42
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 30
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 23
NUP214-ABL1 fusion in childhood T-ALL 15
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 13
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 11
Totale 3.653
Categoria #
all - tutte 12.483
article - articoli 12.483
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019274 0 0 0 0 0 0 0 0 0 49 117 108
2019/2020828 83 33 9 36 76 65 95 100 117 106 66 42
2020/2021660 66 77 30 56 41 18 38 53 68 78 69 66
2021/2022657 30 58 73 34 30 36 113 46 28 15 75 119
2022/2023573 94 79 17 87 70 70 0 39 68 7 34 8
2023/2024212 11 50 30 22 22 30 16 10 7 14 0 0
Totale 3.653